Menu Search
Equities

Theraclion SA

941:STU

Theraclion SA

Actions
  • Price (EUR)0.361
  • Today's Change-0.003 / -0.82%
  • Shares traded0.00
  • 1 Year change-23.19%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Theraclion SA is a France-based company, which develops High Intensity Focused Ultrasound (HiFu) machines. The Company is a a spin-off of Inserm and EDAPTechomed. The main activity of the Company is developping, manufacturing and marketing echotherapy medical equipments associating therapy by focused ultrasound and monitoring by ultrasound. The Company provides Echopulse, a device for the non-invasive and outpatient treatment of the fibroadenoma of the breast and thyroid nodules.

  • Revenue in EUR (TTM)1.28m
  • Net income in EUR-3.56m
  • Incorporated2004
  • Employees28.00
  • Location
    Theraclion SA244, avenue Pierre BrossoletteMALAKOFF 92240FranceFRA
  • Phone+33 155489070
  • Fax+33 155489078
  • Websitehttps://www.theraclion.fr/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.